Catalyst Wire Dossier Catalyst Wire Dossier

Org 26576

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Org 26576, covering 2014-07-02 to 2014-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001) [Phase 2]

See pricing